AccessHope Secures $33 Million to Expand Cancer Care Expertise –

What you should know:

– AccessHope, a company revolutionizing the way cancer patients receive advanced treatment plans, raises $33 million in a Series B funding round led by City of Hope, a leading cancer research and treatment organization.

– The company plans to use the investment to fuel AccessHope’s next phase of growth as a standalone company.

New CEO Bradley Kreick takes over

To lead this growth journey, AccessHope has appointed seasoned healthcare veteran Bradley Kreick as its new CEO. Kreick brings 30 years of experience in leading businesses through periods of significant growth, ideally positioned to guide AccessHope’s commercial expansion. Mark Stadler, the former CEO of AccessHope, will transition to the role of Chief Growth Officer, focusing on expanding the benefits of cancer care across health plans, Medicare and government programs.

Cancer Collaborative Network

AccessHope’s success depends on its unique collaboration with some of the leading National Cancer Institute (NCI)-designated comprehensive cancer centers, including City of Hope, Dana-Farber Cancer Institute and Johns Hopkins Medicine. Through these partnerships, AccessHope provides its members with access to a network of more than 350 top oncologists, covering all cancer types and stages.

Delivering expertise where patients need it most

AccessHope’s innovative approach empowers local oncologists by providing access to the latest insights in cancer treatment from leading cancer centers. This collaboration ensures that patients can benefit from the latest knowledge without leaving their local healthcare providers. AccessHope currently offers its services to more than seven million members through partnerships with more than 400 employers, including more than 60 Fortune 500 companies.

“AccessHope was founded with the mission to bring cutting-edge cancer care knowledge to the places and people who need it most. Today, we are proud to serve nearly seven million members through more than 400 employers, including more than 60 Fortune 500 companies and two of the nation’s largest health plans,” said Harlan Levine, MD, Chairman of the Board of AccessHope and president of Health Innovation and Policy at City of Hope. “As demand for personalized cancer care benefits offered by AccessHope continues to grow, this is an ideal time for City of Hope to provide strategic financing and the autonomy to operate as a standalone company. This move will enable AccessHope to accelerate innovation and expand into new markets and regions, while continuing to expand access to the best expertise in cancer treatment, no matter who you are and where you live.”